11 – 20 of 305
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
How can Alzheimer's disease blood-based biomarkers reach clinical practice?
- Contribution to journal › Article
-
Mark
Modernizing diagnosis of Alzheimer's disease : A review of global trends and Asia-specific perspectives
- Contribution to journal › Scientific review
-
Mark
Lymphomas : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Contribution to journal › Article
-
Mark
Alzheimer's Association Clinical Practice Guideline on the use of blood-based biomarkers in the diagnostic workup of suspected Alzheimer's disease within specialized care settings
- Contribution to journal › Article
-
Mark
Updated Appropriate Use Criteria for Amyloid and Tau PET : A Report from the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
- Contribution to journal › Article
-
Mark
Long COVID clinical evaluation, research and impact on society : a global expert consensus
- Contribution to journal › Article
-
Mark
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease
- Contribution to journal › Scientific review
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2025 Update
- Contribution to journal › Debate/Note/Editorial
-
Mark
Can Plasma ADAMTS13 Differentiate Patients With Pulmonary Arterial Hypertension From Other Forms of Pulmonary Hypertension and Dyspnea Control Patients
- Contribution to journal › Article
-
Mark
OARSI initiative to develop classification criteria for early-stage symptomatic knee OA (EsSKOA) : What conditions should be considered in the differential diagnosis of EsSKOA?
- Contribution to journal › Article
